trulicity glp 1 Lilly's Easy-to Use Once-Weekly GLP-1 Agonist Approved in Europe Battle of GLP-1 delivery technologies

(2017) 12:e0169635

has grown 49% over six months, from 90,500 monthly searches in September 2025 to over 135,000 by February 2026

Directions:1 softgel capsule, 1-2 times daily, with meals, or as directed by a health professional

doi: 10.3390/biomedicines10082019 45 Dreher-LesnickS

The incidences of type 2 diabetes mellitus, hypertriglyceridemia, hypercholesterolemia, and hypertension decreased from 32.6%, 37.7%, 33.4%, and 44.9% (pre-IGB) to 21.3%, 17.4%, 18.9%, and 34.8% respectively at 12 months post IGB removal

Currently, only a minority of state Medicaid programs cover GLP-1s indicated for chronic weight management, but the landscape is fluid as Medicaid decision makers attempt to strike a balance between expanding treatment options for obesity and state budget limitations